Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Diuretics Reduce Risk of Death From Congestive Heart Failure

14.02.2006


Diuretics reduce the risk of death, delay heart deterioration and improve exercise capacity in patients with congestive heart failure, a new review of studies shows.



Although widely used for quick relief of CHF symptoms — cough, shortness of breath and swelling in the feet, legs and ankles — up until now it was not known whether diuretics had a more substantial effect in treating CHF.

“The available data from several small trials show that in patients with chronic heart failure, conventional diuretics appear to reduce the risk of death and worsening heart failure compared to placebo,” according to the review team led by Dr. Rajaa Faris of Saudi Arabia.


Diuretics, which help the body get rid of excess fluid, should be used in conjunction with other heart medications in treating CHF, the reviewers said.

The review appears in the most recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The researchers looked at data from 525 patients from 14 randomized clinical trials — seven comparing diuretics with placebo and seven comparing diuretics with other heart medications in treating CHF. The studies involved three types of diuretics: thiazide, potassium-sparing and loop diuretics, such as Lasix.

Sixty-one percent of the participants were men with an average age of 59.

The authors estimate that “80 deaths could be avoided for every 1,000 patients treated” with diuretics for CHF, but add that this evidence was based on only 15 deaths out of 221 participants from the studies that reported mortality rates.

CHF, also known as heart failure and cardiac failure, involves a decrease in the heart’s ability to pump blood efficiently through the body, leading to a lower delivery of nutrients and oxygen to the cells and causing symptoms such as fatigue, shortness of breath and difficulty with even basic physical activity.

Five million Americans have CHF and 550,000 new cases are diagnosed yearly, according to the American Heart Association. There is no cure or surgical treatment for the disorder and physicians rely on a variety of medications to control symptoms and decrease damage to the heart and other organs in the body while improving patients’ quality of life.

But some doctors question whether the benefits of the drugs outweigh the risks. Diuretics can have serious side effects such as depleting electrolytes (potassium and magnesium), which can contribute to irregular heartbeat and kidney disorders.

“Diuretics are effective, easy to administer and inexpensive,” said Clyde W. Yancy, M.D., with the University of Texas Southwestern Medical Center in Dallas. “Excessive use of diuretics provokes renal [kidney] insufficiency. Importantly, changes in renal function do impart an additional risk for patients with heart failure.”

Proper dosing, Yancy said, is key. “The hope is that physicians will use diuretics in a manner sufficient to relieve evidence of congestion but not to the extent that the risks of disturbance of electrolytes and renal function occur.

“Few drugs are as immediately effective for heart failure as diuretics,” Yancy added. “Any patient in whom these drugs are prescribed should feel at ease with the therapy, provided they are under the care of a team of health care professionals who are actively evaluating electrolyte balance and kidney function.”

The Cochrane reviewers say that many of the studies they analyzed were small, with varying types and doses of diuretics compared, and that further research is needed to understand the optimal use and benefits of diuretic treatment

A large, long-term study of diuretic treatment for older adults with high blood pressure in a recent American Journal of Cardiology found that although those on the drug had a slightly higher risk of developing diabetes, the death rate from heart attack or stroke was significantly reduced.

Rajaa Faris | EurekAlert!
Further information:
http://www.hbns.org
http://www.cfah.org

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>